Success Metrics

Clinical Success Rate
74.5%

Based on 35 completed trials

Completion Rate
74%(35/47)
Active Trials
33(32%)
Results Posted
46%(16 trials)
Terminated
12(12%)

Phase Distribution

Ph phase_4
2
2%
Ph phase_1
17
17%
Ph early_phase_1
3
3%
Ph phase_3
3
3%
Ph not_applicable
14
14%
Ph phase_2
42
41%

Phase Distribution

20

Early Stage

42

Mid Stage

5

Late Stage

Phase Distribution81 total trials
Early Phase 1First-in-human
3(3.7%)
Phase 1Safety & dosage
17(21.0%)
Phase 2Efficacy & side effects
42(51.9%)
Phase 3Large-scale testing
3(3.7%)
Phase 4Post-market surveillance
2(2.5%)
N/ANon-phased studies
14(17.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

35 of 49 finished

Non-Completion Rate

28.6%

14 ended early

Currently Active

33

trials recruiting

Total Trials

102

all time

Status Distribution
Active(39)
Completed(35)
Terminated(14)
Other(14)

Detailed Status

Completed35
Recruiting26
unknown14
Terminated12
Active, not recruiting7
Not yet recruiting5

Development Timeline

Analytics

Development Status

Total Trials
102
Active
33
Success Rate
74.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (3.7%)
Phase 117 (21.0%)
Phase 242 (51.9%)
Phase 33 (3.7%)
Phase 42 (2.5%)
N/A14 (17.3%)

Trials by Status

not_yet_recruiting55%
active_not_recruiting77%
withdrawn22%
recruiting2625%
completed3534%
enrolling_by_invitation11%
terminated1212%
unknown1414%

Recent Activity

Clinical Trials (102)

Showing 20 of 102 trialsScroll for more
NCT06487481Phase 1

Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

Recruiting
NCT07748481

Comparison of the Therapeutic Efficacy of Non-touch Microwave Ablation, Tumor-puncture Microwave Ablation and Surgical Resection for Subcapsular Hepatocellular Carcinoma

Not Yet Recruiting
NCT06908031Phase 2

SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer

Completed
NCT07741344Phase 2

Study of Robotic Assisted/Image Guided Electromagnetic Navigation Bronchoscopic Therapies and Surgery in Stage IA NSCLC

Not Yet Recruiting
NCT06239272Phase 1

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Recruiting
NCT07732634Phase 2

RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer

Not Yet Recruiting
NCT03247712Phase 1

Neoadjuvant Immunoradiotherapy in Head & Neck Cancer

Active Not Recruiting
NCT02481635Phase 1

A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer

Completed
NCT04037527Phase 1

Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities

Terminated
NCT07549399Phase 3

SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC

Recruiting
NCT07671495Phase 2

Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin

Completed
NCT05516628Phase 2

Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma

Recruiting
NCT01871766Phase 2

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Active Not Recruiting
NCT06023641Phase 2

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

Recruiting
NCT06492954Phase 1

Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

Recruiting
NCT06800339Phase 1

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

Recruiting
NCT05546827Phase 2

Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma

Recruiting
NCT03772119

Assessment and Follow-up of Surgical Treatment of Hemivertebra in Children

Recruiting
NCT04968990Phase 2

Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation

Recruiting
NCT01857934Phase 2

Therapy for Children With Advanced Stage Neuroblastoma

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
102